Cancer

Second NHS trust trials drone deliveries for chemotherapy medicines

The trial will collect logistical data to ensure the drones can safely transport the medicine between hospital sites in Northumbria.…

Recent antibiotic reduces cancer survival after immune checkpoint inhibitors by 12%, study results show

Results from a Canadian cohort study suggest that antibiotic therapy may reduce the effectiveness of immune checkpoint inhibitor therapy.…

Community pharmacies to start directly referring patients for cancer screening from January 2023

Exclusive: The first phase of the pilot is planned to begin this month, with further pharmacies to start referring patients in March/April 2023.…

Cancer vaccine combined with monoclonal antibody cuts risk of death or recurrence of melanoma by almost 50%, show phase II trial data

Experts say the data are exciting, but warn larger trials are needed in other cancer types.…

Overview of cancer treatment-related cardiovascular toxicity

A closer look at the common cardiovascular conditions that can occur in people with cancer and their drug associations, as well as management considerations.…

Monoclonal antibodies for the treatment of multiple myeloma

An overview of the development and use of monoclonal antibodies in the treatment of patients with multiple myeloma.…

Don’t dismiss fears over switching generics, take it from two cancer ‘thrivers’

Ruth Edwards and Avril Chester share their experience of the impact medicines shortages can have on people who rely on long-term medicines after cancer treatment.…

The role of circulating tumour DNA in guiding cancer treatment and future applications

An overview of current and future applications of circulating tumour DNA in common solid tumours and the implications on treatment.…

Immune-related cancer toxicities: what pharmacists need to know

In this episode of The PJ Pod, we explore the side effects of cancer immunotherapy and consider what pharmacists can do to support patients throughout the course of their treatment.…

Supported content

Medication restrictions for patients receiving CAR-T therapy

To assure the quality of CAR-T therapy and optimise the chances of successful treatment, pharmacists caring for CAR-T patients must be aware of the medication restrictions — prior to and following treatment — and their rationale.…